Observational analysis shows higher hemagglutinin activation in ciliated cells than non-ciliated types, indicating important antiviral development considerations.
Key Points
Ciliated cells activate hemagglutinin more effectively, enhancing influenza A virus potential.
Efficient hemagglutinin activation varies by cell type, impacting antiviral strategies.
Activation starts within the Golgi, limiting the effectiveness of protease inhibitors.
Understanding cellular tropism informs the development of novel antiviral approaches.